I agree that this site is using cookies. You can find further informations here.
X
Sullivan, Ryan J.
1078  results:
OpenAccess-fulltext X
Search for persons X
?
1

Eganelisib, a First-in-Class PI3Kγ Inhibitor, in Patients w..:

Hong, David S ; Postow, Michael ; Chmielowski, Bartosz...
qt6h50s9vr.  , 2023
Link: https://escholarship.org..
 
?
2

Eganelisib, a First-in-Class PI3K- [Formula: see text] Inhi..:

Hong, David S ; Postow, Michael ; Chmielowski, Bartosz...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388696/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
3

Tebentafusp in the Treatment of Metastatic Uveal Melanoma: ..:

Montazeri, Kamaneh ; Pattanayak, Vikram ; Sullivan, Ryan J
info:eu-repo/semantics/altIdentifier/doi/10.2147/DDDT.S368954.  , 2023
Link: https://www.dovepress.co..
 
?
4

Society for Immunotherapy of Cancer (SITC) consensus defini..:

Atkins, Michael B ; Ascierto, Paolo A ; Feltquate, David...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016252/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
5

Toxicities associated with immune checkpoint inhibitors: a ..:

Kong, Xiangyi ; Chen, Li ; Su, Zhaohui...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389211/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
6

Improving Multiple Sclerosis Lesion Segmentation Across Cli..:

Bai, Lei ; Wang, Dongang ; Barnett, Michael...
http://arxiv.org/abs/2308.16376.  , 2023
Link: http://arxiv.org/abs/230..
 
?
7

Multiple sclerosis lesion segmentation: revisiting weightin..:

Liu, Dongnan ; Cabezas, Mariano ; Wang, Dongang...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232857/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
8

The "Great Debate" at Immunotherapy Bridge 2022, Naples, No..:

Ascierto, Paolo A ; Brentjens, Renier ; Khleif, Samir N...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122806/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
9

Editorial: Edema in heart failure with reduced ejection fra..:

Gladysheva, Inna P ; Sullivan, Ryan D ; Pellicori, Pierpaolo
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941704/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
10

Phase 1b study of intravenous coxsackievirus A21 (V937) and..:

Lutzky, Jose ; Sullivan, Ryan J ; Cohen, Justine V...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356892/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
11

Multicenter Evaluation of Radiation and Immune Checkpoint I..:

Smart, Alicia C ; Giobbie-Hurder, Anita ; Desai, Vineet...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10801653/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
12

Phase Ib Trial of Phenformin in Patients with V600-mutated ..:

Chapman, Paul B ; Klang, Mark ; Postow, Michael A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695100/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
13

Gradient Informed Proximal Policy Optimization:

Son, Sanghyun ; Zheng, Laura Yu ; Sullivan, Ryan..
http://arxiv.org/abs/2312.08710.  , 2023
Link: http://arxiv.org/abs/231..
 
?
14

Addressing resistance to PD-1/PD-(L)1 pathway inhibition: c..:

Zhang, Tian ; Forde, Patrick M ; Sullivan, Ryan J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163527/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
15

Society for Immunotherapy of Cancer (SITC) consensus defini..:

Rizvi, Naiyer ; Ademuyiwa, Foluso O ; Cao, Z Alexander...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016262/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
1-15